Immuron CEO to Present at RedChip Global Online Growth Conference

    NEXT STORY
    Axiom Real-Time Metrics Exhibiting Fusion eClinical Suite at Clinical Operations in Oncology Trials West
    PREV STORY
    Surface Oncology Announces Closing of $119.5 Million Aggregate Financing, Consisting of $108.0 Million Initial Public Offering and $11.5 Million Concurrent Private Placement
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Iovance Biotherapeutics Announces Results of a Subgroup Analysis of Patients in the Lifileucel Metastatic Melanoma Study who are Primary Refractory to Anti-PD-1/L1 Therapy

    author_avatar
    NASDAQ Market News

    Intra-Cellular Therapies Presents Data on Lumateperone, ITI-214 and ITI-333 at the 56th Annual Meeting of the American College of Neuropsychopharmacology

    NEW YORK, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    Kitware Funds Project to Aid Critical Care Physicians Treating Multiple COVID-19 Patients with a Shared Ventilator

    author_avatar
    NASDAQ Market News